That TikTok Toenail Fungus Product Won't Work. Here's What Actually Does. (A Pharmacist Explains)
By a licensed pharmacist with 9 years of clinical experience
You've seen the ads.
A video pops up on your feed showing a dark, thick, discolored toenail — and then, like magic, it transforms into a clean, healthy-looking nail after just a few weeks of using some $30 serum.
The comments are full of people saying it changed their life. The brand promises a full refund if it doesn't work. The ingredients sound natural and safe.
And the price? Just $25 to $50. Tempting enough to make you reach for your credit card.
I get it. I really do.
But as a pharmacist, the first thing I do when I see one of these ads is look up exactly what kind of product it is.
Every single time, the answer is the same: a cosmetic or an over-the-counter wellness product.
And that's when I close the tab.
Today I want to explain why — and walk you through what the clinical evidence actually says about treating toenail fungus.
Table of Contents
- What's the difference between a cosmetic and a real medication?
- What's actually inside these social media products?
- What is efinaconazole (Jublia)?
- How does it actually kill the fungus?
- Why nail penetration is the key — and why most products fail here
- What do the clinical trials actually show?
- How to use it correctly
- Side effects
- Special populations: older adults, diabetics, and pregnant women
- The bottom line
1. What's the difference between a cosmetic and a real medication?
Most people don't think about this distinction — but it matters enormously when it comes to toenail fungus.
In the US and most of Europe, health products are regulated in a hierarchy. Here's the simplified version:
| Category | Examples | What it means |
|---|---|---|
| Prescription drug | Jublia (efinaconazole), antibiotics, statins | Requires a prescription. Efficacy proven in clinical trials. FDA-approved. |
| OTC medication | Tylenol, antacids, OTC antifungal creams | No prescription needed. Still regulated by the FDA for safety and efficacy. |
| Cosmetic / wellness product | Most social media "nail serums" | Minimal regulation. No requirement to prove it actually treats any condition. |
That last category is the problem.
Cosmetics and wellness products don't have to prove they work. They just can't legally claim to treat a disease — which is why you'll notice these ads say things like "promotes healthy-looking nails" or "addresses nail discoloration" instead of "treats toenail fungus." That's not an accident. It's a legal workaround.
And because they're not classified as drugs, they can run aggressive social media ads that prescription medications simply cannot.
2. What's actually inside these social media products?
Let's look at what these nail serums are typically made of:
- Glycerin, panthenol, hyaluronic acid — moisturizers. The same stuff in your face lotion.
- Tea tree oil, lavender oil — aromatherapy oils. They smell nice. That's about it.
- Hydrogen peroxide — a surface disinfectant. Used to clean minor cuts.
- Niacinamide, biotin — skincare nutrients. Good for skin health, completely irrelevant to nail fungus.
Here's the thing about hydrogen peroxide specifically. When you apply it to a nail, it fizzes and bubbles up. And when you see that reaction, it feels like something is happening — like the fungus is being destroyed.
It isn't.
That's just surface oxidation. The fungus living deep inside your nail plate is completely unaffected.
I'll be honest: I have a grudging respect for whoever designed that marketing. Getting a visible, dramatic-looking reaction out of a basic disinfectant — and making people associate it with "killing the fungus" — is genuinely clever. But clever marketing isn't the same as clinical efficacy.
Now here's the fundamental problem with all of these ingredients:
Your toenail is a dense block of a protein called keratin. It's thick, hard, and extraordinarily difficult for topical substances to penetrate. The fungus isn't sitting on the surface of your nail — it's underneath the nail plate, feeding on the nail bed.
Tea tree oil and lavender oil cannot penetrate through dense keratin to reach a fungal infection living underneath. Neither can hydrogen peroxide. Neither can any moisturizer.
So when a product promises to clear toenail fungus in two weeks using these ingredients, it's not just unlikely.
It's not physiologically possible.
💡 Quick note on cost: These products typically run $25–$50 per bottle. Jublia, which is a prescription antifungal, can cost significantly more without insurance — sometimes $150+ per bottle in the US. We'll talk about that. But the point is: if you're going to spend money on your toenails, spend it on something that has been clinically proven to work.
3. What is efinaconazole (Jublia)?
Efinaconazole 10% topical solution — sold under the brand name Jublia in the US and Canada, and approved in Japan as well — is a prescription antifungal medication developed specifically for toenail onychomycosis (the clinical term for toenail fungus).
It was approved by the US FDA in 2014, making it one of the more recently developed topical antifungals available.
The fact that it requires a prescription matters. It means it went through rigorous phase II and phase III clinical trials before it was allowed on the market. Its efficacy had to be demonstrated in real patients, with real controls, and evaluated by independent regulators.
That is a fundamentally different standard than anything sold as a cosmetic or wellness product.
4. How does it actually kill the fungus?
The main culprit in most toenail fungus infections is a dermatophyte called Trichophyton rubrum. Don't worry about the name — just think of it as the fungus that colonizes your nail and feeds on keratin.
Like all living cells, this fungus needs a healthy cell membrane to survive. And to build that membrane, it relies on a compound called ergosterol. Think of ergosterol as the essential construction material for the fungal cell wall.
Here's what efinaconazole does:
It blocks an enzyme called lanosterol 14-alpha demethylase. That enzyme is a critical step in the production of ergosterol. When the enzyme is blocked, ergosterol production shuts down. Instead, toxic sterol byproducts start accumulating inside the fungal cell. The cell membrane deteriorates. The fungus can no longer grow — and eventually dies.
This mechanism is shared by other antifungal drugs in the "azole" class, such as itraconazole and fluconazole. What makes efinaconazole different is not how it kills fungus — it's how well it gets to the fungus in the first place.
5. Why nail penetration is the key — and why most products fail here
This is the part that most people miss, and it's where efinaconazole genuinely separates itself from older treatments.
Here's something counterintuitive: you might think that a drug which binds strongly to nail tissue would be better at penetrating it. If it sticks, it must be getting deep in, right?
Actually, the opposite is true.
Your nail plate is made of densely packed keratin. When a topical drug has high keratin affinity — meaning it binds strongly to keratin — it gets trapped at the surface. It latches onto the outermost layer of the nail and can't move any further inward.
Think of it like trying to walk through a crowded room while wearing a velcro suit. You'd stick to the first thing you touched and never make it to the other side.
The fungus is deep underneath the nail plate — on the nail bed. The drug needs to get all the way down there.
If it gets stuck on the surface, it doesn't matter how potent it is.
Efinaconazole has low keratin affinity. It doesn't stick. Instead of getting trapped at the nail surface, it moves freely through the nail plate — all the way down to where the fungus actually lives.
Researchers tested this directly. When efinaconazole was placed in a keratin suspension, significantly more of the drug remained free and unbound compared to older topical antifungals like ciclopirox. Free drug is drug that can keep moving. Drug that keeps moving can reach the infection site.
And in laboratory studies on actual nail samples, efinaconazole was detected throughout the full thickness of the nail plate — including the deepest layers, where the fungal infection is concentrated.
This isn't true of tea tree oil. It isn't true of hydrogen peroxide. It isn't true of most OTC antifungal lacquers. Getting through keratin is hard, and most substances simply can't do it effectively.
6. What do the clinical trials actually show?
Two large, identical, randomized, double-blind, placebo-controlled Phase III trials were conducted across sites in the United States, Canada, and Japan — with over 1,600 participants total.
Participants applied either efinaconazole 10% solution or a placebo vehicle once daily for 48 weeks. Results were evaluated at week 52.
| Outcome | Efinaconazole | Placebo |
|---|---|---|
| Mycological cure (fungus completely gone on lab testing) | ~55% | ~17% |
| Complete cure (zero visible infection + mycological cure) | 17–18% | 3–5% |
A complete cure rate of 17–18% might sound low. But context matters a lot here.
Toenail fungus is genuinely one of the hardest conditions to treat topically. The previous standard topical antifungal — ciclopirox 8% lacquer — had a complete cure rate of around 5–8%. Efinaconazole more than doubled that.
When compared to oral antifungals like itraconazole, the mycological cure rates are in a comparable range. A topical medication achieving similar fungal eradication rates to a systemic oral drug is a meaningful clinical result.
A longer Japanese study followed patients for 72 weeks, including those with severe infections covering more than 50% of the nail. Results continued to improve the longer treatment was maintained:
- Mycological cure at 72 weeks: 62%
- Complete cure at 72 weeks: 31%
- Week 72 results were better than week 60, which were better than week 48
The takeaway: the longer you use it, the better it works. This is consistent with how toenail regrowth works biologically — the nail needs to grow out before complete clinical clearance is visible.
References:
- Elewski et al. (2013) — Phase III trials, JAAD
- Gupta et al. (2014) — Pooled analysis, mild to moderate onychomycosis
- Rodriguez (2015) — Subgroup analysis by disease severity
- Iozumi et al. (2019) — 72-week long-term study including severe cases
- Lipner et al. (2025) — Efficacy in adults aged 65 and older
- Gupta et al. (2025) — Efinaconazole in diverse patient populations
7. How to use it correctly
Even the best medication won't work if it's applied incorrectly. Here's what the research and prescribing guidelines say:
① Dry your nails completely before applying
Wait at least 10 minutes after showering or bathing before applying the solution. Using a hairdryer on a low setting to dry the nail area thoroughly is a good approach. Water dilutes the medication and impairs penetration.
② Cover the entire nail — not just the top surface
Apply to the nail surface, the sides of the nail, the edges, and the skin-nail border. Fungus tends to concentrate in corners and under edges. Missing those areas reduces efficacy.
③ Don't stop early
This is where most people fail. When things start to look better after a few months, the temptation is to stop. Don't. The nail has to fully grow out before the infection is truly cleared. Stopping early almost always leads to relapse. Plan for a minimum of 12 months of daily application.
④ What about nail polish?
Research has shown that regular nail polish does not significantly reduce efinaconazole's penetration through the nail. You don't need to remove it before applying. However, thick gel nails applied in multiple layers may be a different situation — in that case, removing the gel first is the safer option. One practical note: efinaconazole can discolor and change the texture of nail polish over time. Using a darker shade and applying both a base coat and top coat can help minimize this effect.
⑤ Treat athlete's foot at the same time
Research found that about 20% of people with toenail onychomycosis also have concurrent athlete's foot (tinea pedis). If the athlete's foot is left untreated, the fungus from the skin keeps reinfecting the nail — even after the nail treatment is working. Treating both conditions simultaneously significantly improves outcomes.
8. Side effects
Systemic side effects are extremely rare with efinaconazole. The amount of the drug absorbed into the bloodstream through topical application is negligible — measured in clinical studies, blood concentrations were barely detectable.
This is one of the most important practical advantages over oral antifungals. Oral medications like terbinafine and itraconazole carry real risks of liver stress and drug-drug interactions. Efinaconazole, applied topically, largely sidesteps those concerns.
The most common side effects are local reactions at the application site:
- Mild redness or irritation
- Itching
- Small blisters
These occurred in roughly 2% of patients in clinical trials and resolved when treatment was stopped. No serious adverse events were reported in connection with the medication itself.
9. Special populations: older adults, diabetics, and pregnant women
Older adults (65+)
Toenail fungus becomes more common with age — some estimates suggest up to 50% prevalence by age 70. Older adults also present additional treatment challenges: thicker nails, slower nail growth, reduced circulation to the extremities, and a higher likelihood of taking multiple medications.
A post-hoc analysis of the Phase III trial data, looking specifically at participants aged 65–71, found that efinaconazole performed comparably to its results in the overall study population. Mycological cure was achieved in about 59% of older participants, and complete cure in about 13.6%.
Because efinaconazole penetrates the nail directly rather than relying on blood flow, reduced peripheral circulation doesn't affect how well it works. And because systemic absorption is minimal, the drug interaction concerns that make oral antifungals complicated for older adults on multiple medications largely don't apply.
People with diabetes
Toenail fungus affects approximately one in three people with diabetes — and in this population, an untreated nail infection carries real medical risks, including the potential for secondary bacterial infections, ulceration, and in severe cases, complications that can threaten limb health.
Clinical data on efinaconazole in diabetic patients showed similar efficacy to the general population, and importantly, no significant correlation between glycemic control (HbA1c levels) and treatment outcomes. In other words, it worked regardless of how well blood sugar was managed.
If you have diabetes and toenail fungus, don't ignore it. Get it treated.
Pregnant and breastfeeding women
⚠️ Important: If you are pregnant or breastfeeding, do not use efinaconazole without first consulting your doctor. Animal studies at high doses showed potential effects on fetal development. The amounts absorbed through topical application in humans are very small, but safety in pregnant and breastfeeding women has not been fully established in clinical trials. This is not a decision to make on your own — talk to your healthcare provider.
10. The bottom line
If you've been spending money on social media nail serums hoping they'll clear up toenail fungus, I understand the appeal. They're affordable, they look convincing, and the before-and-after videos are hard to ignore.
But the ingredients in those products — moisturizers, aromatherapy oils, surface disinfectants — cannot penetrate through dense nail keratin to reach a fungal infection living underneath.
The two-week transformation you see in those videos is not physiologically possible with those substances.
Toenail fungus is a real, stubborn, chronic infection. Treating it effectively requires a medication that can actually get through the nail. Efinaconazole was specifically engineered to do exactly that, and it's backed by large, independent, peer-reviewed clinical trials.
That said, it's not a miracle cure either. You need to apply it every day for at least a year. You need to use it correctly. And you need to address any concurrent athlete's foot.
Consistency is what separates people who get results from people who don't.
If you think you have toenail fungus, see a dermatologist or talk to your pharmacist. Get a proper diagnosis first — nail discoloration can have other causes, and you don't want to treat for the wrong thing. If it is onychomycosis, ask about your options, including efinaconazole.
References
- Elewski BE et al. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol. 2013.
- Gupta AK et al. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials. 2014.
- Rodriguez DA. Efinaconazole Topical Solution, 10%, for the Treatment of Mild and Moderate Toenail Onychomycosis. 2015.
- Iozumi K et al. Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases. 2019.
- Lipner SR et al. Efficacy and Safety of Efinaconazole 10% Topical Solution for Treatment of Onychomycosis in Older Adults: A Post Hoc Analysis of Two Phase 3 Randomised Trials. 2025.
- Gupta AK et al. Treating Onychomycosis with Efinaconazole: Considerations for Diverse Patient Groups. 2025.
- U.S. Food and Drug Administration — Drug Approvals Database
⚠️ Disclaimer
This article was written by a licensed pharmacist based on peer-reviewed clinical research and publicly available prescribing information. It is intended for general informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medication vary based on health status, infection severity, and other factors. Efinaconazole (Jublia) is a prescription medication — it cannot be purchased without a valid prescription from a licensed healthcare provider. Always consult your doctor or pharmacist before starting, stopping, or changing any treatment. The author has no financial relationship with any pharmaceutical company mentioned in this article.
Comments
Post a Comment